We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Embryonic Stem Cells Created Without Embryo

By LabMedica International staff writers
Posted on 11 Feb 2014
US and Japanese researchers have demonstrated that any mature adult cell, known as a somatic cell, has the potential to change into the equivalent of an embryonic stem cell.

Scientists have had great expectations for their use in treating a wider range of diseases because human embryonic stem cells are pluripotent. More...
However, the acquisition of human embryonic stem cells from an embryo can cause the destruction of the embryo, consequently raising ethical concerns. In 2006, researchers introduced an alternative to collecting embryonic stem cells called induced pluripotent stem (iPS) cells.

The investigators revealed that it was possible to send a normal adult cell back to an undifferentiated, pluripotent stem cell state by introducing genetic material into the cell, a process that changes the original state of the cell. To avoid the use of embryonic stem cells, other scientists have focused more on the use of adult stem cells, but the use is of these cells is limited because, dissimilar to embryonic stem cells that grow into any sort of mature cell, adult stem cells can only grow into specific cell types.

The new findings were published in the January 30, 2014, issue of the journal Nature. Researchers from Brigham and Women’s Hospital (BWH; Boston, MA, USA) in collaboration with the RIKEN Center for Developmental Biology (Kobe, Japan) have shown in a preclinical model, a novel and unique way that cells can be reprogrammed, an event they termed stimulus-triggered acquisition of pluripotency (STAP). This process, significantly, does not require introducing new outside DNA, the process typically used to persuade adult cells back into a state of pluripotentency.

“It may not be necessary to create an embryo to acquire embryonic stem cells. Our research findings demonstrate that creation of an autologous pluripotent stem cell—a stem cell from an individual that has the potential to be used for a therapeutic purpose—without an embryo, is possible. The fate of adult cells can be drastically converted by exposing mature cells to an external stress or injury. This finding has the potential to reduce the need to utilize both embryonic stem cells and DNA-manipulated iPS cells,” said senior author Charles Vacanti, MD, chairman of the department of anesthesiology, perioperative and pain medicine and director of the laboratory for tissue engineering and regenerative medicine at BWH and senior author of the study. “This study would not have been possible without the significant international collaboration between BWH and the RIKEN Center,” he added.

Researchers, drawing from the ability of a plant callus—a node of plant cells that is created by injuring an existing plant, to grow into a new plant—hypothesized that any mature adult cell, once differentiated into a specific cell type, could be de-differentiated through a natural process that does not require inserting genetic material into the cells. “Could simple injury cause mature, adult cells to turn into stem cells that could in turn develop into any cell type?” postulated the investigators.

Researchers theorized that these findings raise the possibility that unknown cellular functions that are turned on through external stress, may set mature adult cells free from their current responsibilities and allow them to return to their naïve cell state. “Our findings suggest that somehow, through part of a natural repair process, mature cells turn off some of the epigenetic controls that inhibit expression of certain nuclear genes that result in differentiation,” said Dr. Vacanti.

The researchers noted that the next step is to investigate this process in more advanced mammals and finally in humans. “If we can work out the mechanisms by which differentiation states are maintained and lost, it could open up a wide range of possibilities for new research and applications using living cells. But for me the most interesting questions will be the ones that let us gain a deeper understanding of the basic principles at work in these phenomena,” said first author Haruko Obokata, PhD.

If this same process can be demonstrated in human cells, then someday, through a skin biopsy or blood sample, without the need for genetic manipulation, researchers may be able to generate embryonic stem cells specific to each individual, which then could be used to create tissue without having to insert any outside genetic material into that cell, creating endless possibilities for therapeutic options.

Researchers reported that there are still more questions about the process. Dr. Vacanti and colleagues are interested in examining why and how stressful stimuli drive reprogramming to create the pluripotent state.

Related Links:

Brigham and Women’s Hospital
RIKEN Center for Developmental Biology




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.